Profile data is unavailable for this security.
About the company
Cryosite Limited is engaged in providing outsourced clinical trials depot services. The Company manages the entire clinical trial supply chain from importation, receipt, specialized ambient, cold, frozen, and liquid nitrogen storage for temperature-sensitive products, distribution and reverse logistics management. Its segments include Ambient, Cold, and Frozen, Ultra Frozen and Cryogenic and Cord blood. The Ambient, Cold, and Frozen segment storages and distributes small-molecule drugs and related products requiring ambient, refrigerated, or frozen conditions. Ultra Frozen and Cryogenic is engaged in specialized handling of materials requiring Ultra-Frozen or Cryogenic conditions, including Advanced Therapy Medicinal Products (ATMPs), such as Cell and Gene Therapies (CGT), cell therapies, and others. The cord blood segment is engaged in storage of cord blood cell and tissue samples for personal or directed therapeutic use, maintained under validated chain-of-identity controls.
- Revenue in AUD (TTM)14.12m
- Net income in AUD1.88m
- Incorporated1999
- Employees25.00
- LocationCryosite Ltd13a Ferndell St, South granvilleSYDNEY 2142AustraliaAUS
- Phone+61 28865-2000
- Fax+61 28865-2090
- Websitehttps://www.cryosite.com/
Mergers & acquisitions
| Acquired company | CTE:ASX since announced | Transaction value |
|---|---|---|
| Freehold Warehouse Facility,Auburn,NSW | 32.53% | 6.28m |
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Genetic Technologies Ltd | 3.71m | -8.65m | 52.08m | 58.00 | -- | -- | -- | 14.05 | -0.0571 | -0.0642 | 0.0247 | -0.0149 | 0.7258 | 10.10 | 5.88 | 63,898.28 | -169.41 | -56.05 | -601.58 | -66.86 | 45.93 | 51.10 | -233.43 | -190.20 | 0.446 | -208.39 | -- | -- | -11.76 | 213.18 | -2.27 | -- | -8.10 | -- |
| Microba Life Sciences Ltd | 15.67m | -14.94m | 52.98m | -- | -- | 1.38 | -- | 3.38 | -0.0333 | -0.0333 | 0.0349 | 0.0631 | 0.2953 | 3.94 | 12.62 | -- | -28.16 | -34.53 | -35.75 | -42.28 | 47.49 | 49.17 | -95.34 | -159.98 | 1.68 | -- | 0.0904 | -- | 29.60 | 40.04 | 25.07 | -- | 27.63 | -- |
| Cryosite Ltd | 14.12m | 1.88m | 53.69m | 25.00 | 29.13 | 22.47 | 19.49 | 3.80 | 0.0378 | 0.0378 | 0.2834 | 0.049 | 0.7206 | 102.47 | 7.87 | 564,640.00 | 9.62 | 6.66 | 12.29 | 8.09 | 62.98 | 60.87 | 13.35 | 11.83 | 1.95 | -- | 0.4869 | -- | 11.93 | 9.38 | 2.39 | 4.94 | -8.42 | -- |
| Cleo Diagnostics Ltd | 1.18m | -4.00m | 82.12m | -- | -- | 13.21 | -- | 69.31 | -0.0314 | -0.0314 | 0.0092 | 0.0454 | 0.1409 | -- | 18.51 | -- | -47.57 | -- | -52.53 | -- | -- | -- | -337.54 | -- | -- | -- | 0.00 | -- | 97.41 | -- | -6.38 | -- | -- | -- |
| Apiam Animal Health Ltd | 206.92m | 832.00k | 160.98m | -- | 230.77 | 1.32 | 11.82 | 0.778 | 0.0038 | 0.0038 | 1.11 | 0.6613 | 0.809 | 4.57 | 15.75 | -- | 0.3378 | 1.65 | 0.3896 | 1.93 | 66.22 | 63.46 | 0.4175 | 1.97 | 0.5026 | 2.33 | 0.4586 | 71.37 | 1.11 | 11.83 | -83.13 | -27.29 | 27.96 | 0.3129 |
| Eureka Group Holdings Ltd | 45.79m | 20.06m | 211.16m | 42.00 | 9.78 | 0.8739 | 10.28 | 4.61 | 0.0506 | 0.0506 | 0.1189 | 0.5664 | 0.1506 | -- | 206.26 | -- | 6.60 | 6.12 | 6.75 | 6.29 | 54.76 | 52.75 | 43.81 | 37.02 | -- | -- | 0.1908 | 30.22 | 11.30 | 13.04 | 51.90 | 19.90 | 21.25 | 6.71 |
